Incomplete response to colchicine in M694V homozygote FMF patients

Autoimmunity Reviews

Volumn 12, Issue 1, 2012, Pages 72-76

  Lidar, Merav ^a,c   Yonath, Hagith ^a,b,c   Shechter, Naama ^b   Sikron, Fabienne ^b   Sadetzki, Siegal ^b,c   langevitz, Pnina ^a,c   Livneh, Avi ^a,c   Pras, Elon ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colchicine; FMF; M69V homozygotes; Mutation; None responders

Indexed keywords

COLCHICINE;

CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HOMOZYGOTE; HUMAN; REVIEW; TREATMENT RESPONSE;

ADULT; AGED; COLCHICINE; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; YOUNG ADULT;

EID: 84866843896     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.025     Document Type: Review

References (26)

1. Sohar E., Gafni J., Pras M., Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967, 43:227-253.
2. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
3. Kogan A., Shinar Y., Lidar M., Revivo A., Langevitz P., Padeh S., et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001, 102:272-276.
4. Ozer F.L., Kaplaman E., Zileli S. Familial Mediterranean fever in Turkey. A report of twenty cases. Am J Med 1971, 50:336-339.
5. Barakat M.H., Karnik A.M., Majeed H.W. el-Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs: a study of 175 patients and review of the literature. Q J Med 1986, 233:837-847.
6. Rogers D.B., Shohat M., Petersen G.M., Bickal J., Congleton J., Schwabe A.D., et al. Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet 1989, 34:168-172.
7. Zaks N., Shinar Y., Padeh S., Lidar M., Mor A., Tokov I., et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003, 5:585-588.
8. Shinar Y., Livneh A., Langevitz P., Zaks N., Aksentijevich I., Koziol D.E., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000, 27:1703-1707.
9. Zemer D., Revach M., Pras M., Modan B., Schor S., Sohar E., et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974, 291:932-934.
10. Zemer D., Pras M., Sohar E., Gafni J. Continuous colchicine therapy in familial Mediterranean fever. Harefuah 1976, 90:440-442.
11. Soylemezoglu O., Arga M., Fidan K., Gonen S., Emeksiz H.C., Hasanoglu E., et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 2010, 37:182-189.
12. Zemer D., Pras M., Sohar E., Modan M., Cabili S., Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986, 314:1001-1005.
13. Livneh A., Zemer D., Langevitz P., Laor A., Sohar E., Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 1994, 37:1804-1811.
14. Livneh A., Langevitz P., Zemer D., Padeh S., Migdal A., Sohar E., et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996, 26:612-627.
15. Lidar M., Scherrmann J.M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004, 33:273-282.
16. Meinzer U., Quartier P., Alexandra J.F., Hentgen V., Retornaz F., Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011, 41:265-271.
17. Majeed H.A., El-Shanti H., Al-Khateeb M.S., Rabaiha Z.A. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002, 31:371-376.
18. Samuels J., Aksentijevich I., Torosyan Y., Centola M., Deng Z., Sood R., et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998, 77:268-297.
19. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., Livneh A., et al. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003, 48:1149-1155.
20. Mimouni A., Magal N., Stoffman N., Shohat T., Minasian A., Krasnov M., et al. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000, 105:E70.
21. Pras E., Livneh A., Balow J.E., Kastner D.L., Pras M., Langevitz P. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998, 75:216-219.
22. Mor A., Shinar Y., Zaks N., Langevitz P., Chetrit A., Shtrasburg S., et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005, 35:57-64.
23. Lidar M., Scherrmann J.M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004, 33:273-282.
24. Niel E., Scherrmann J.M. Colchicine today. Joint Bone Spine 2006, 73:672-678.
25. Tufan A., Babaoglu M.O., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 2007, 34:1540-1544.
26. Ozen F., Silan C., Uludag A., Candan F., Silan F., Ozdemir S., et al. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients. Ren Fail 2011, 33:899-903.